Vanda Pharmaceuticals Inc.
(NASDAQ : VNDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$838.74m
AMGNAmgen Inc.
0.89%188.341.2%$621.82m
GILDGilead Sciences, Inc.
1.84%67.590.9%$512.40m
BIIBBiogen Inc.
2.51%332.871.3%$445.54m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$305.14m
ILMNIllumina, Inc.
2.51%299.823.5%$302.67m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.75m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$233.68m
LOXOLoxo Oncology Inc
-0.03%234.6612.7%$170.39m
SRPTSarepta Therapeutics, Inc.
2.65%138.4515.4%$148.57m
AAgilent Technologies, Inc.
1.64%78.281.6%$133.87m
INCYIncyte Corporation
0.88%84.152.5%$132.72m
EXASExact Sciences Corporation
0.49%88.5525.3%$128.36m
ARRYArray BioPharma Inc.
4.95%23.138.2%$105.79m
EXELExelixis, Inc.
-0.18%22.266.4%$97.74m

Company Profile

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.